CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- 4 Exercise or conversion Chief Operating Officer acquired 30,450 shares (option exercise)
- 4 Open-market buy 10% owner bought 12,000 shares at $13.55 ($162,600)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 300,000 shares at an average $14.35 ($4,306,343)
- 4 Open-market sale 10% owner sold 9,106 shares at $18.97 ($172,741)
- 4 Open-market sale 10% owner sold 150,000 shares at $15.31 ($2,296,500)
- 4 Open-market sale 10% owner sold 150,000 shares at $15.31 ($2,296,500)
- 4 Open-market sale 10% owner sold 254,612 shares at an average $15.87 ($4,041,238)
- 4 Open-market sale 10% owner sold 254,612 shares at an average $15.87 ($4,041,238)
- 4 Open-market sale Director sold 3,887,500 shares at $16.40 ($63,755,000)
- 4 Open-market sale Director sold 3,887,500 shares at $16.40 ($63,755,000)
- 4 Other disposition Director disposed of 21,154,526 shares (other)
- 4 Open-market sale 10% owner sold 566,297 shares at an average $10.52 ($5,958,964)
- 4 Grant or award Director acquired 5,319 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition Director disposed of 23,855,148 shares (other)
- 4 Other disposition Director disposed of 23,855,148 shares (other)
- 4/A Shares withheld for taxes President and CEO gave up 7,890 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,977 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,497 shares (to pay taxes)
Page 10 of 17 · 321 filings